Back

Non-ischemic cardiomyopathy patient's survival results of the intracardiac device implanted versus medical therapy

12 May 2024 (10:08 - 11:17)
Organised by: Logo
Congress Presentation Part of: ePosters in arrhythmias and device therapy 5 Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mehmet Ruhat Kose

Ege University Hospital, Izmir (Turkiye)

6 More presentations in this session

Presentation thumbnail
Implantable cardioverter-defibrillators in the elderly
Doctor S. Cha (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Quality of life and psychological well-being among heart failure patients living with an implantable cardioverter-defibrillator
Doctor B. Dobai (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
Subcutaneous implantable cardioverter defibrillator: a real world 9 years experience of a portuguese centre
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Predictors of implantable cardioverter-defibrillator therapies: a 6-year follow-up study
Doctor D. De Almeida Fernandes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: real world data from a Portuguese cohort
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in arrhythmias and device therapy 5

The Event

Event poster

Heart Failure 2024

12 May 2024 10:08 CET
You may be interested in
thumbnail
Congress Presentation
Are patients with non-ischemic cardiomyopathy less deserving of primary prevention device implantation?
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator therapies in primary prevention are not decreased in a contemporary cohort: insights from long-term follow-up
thumbnail
Congress Presentation
Clinical outcomes of implantable cardioverter defibrillators in heart failure: a comparative analysis between ischemic and non-ischemic cardiomyopathy patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources